{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:42:10Z","timestamp":1793922130943,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA277680"],"award-info":[{"award-number":["R01CA277680"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Institute","award":["P30-CA051008"],"award-info":[{"award-number":["P30-CA051008"]}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["DICR INTR-23"],"award-info":[{"award-number":["DICR INTR-23"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005384","name":"American Physiological Society","doi-asserted-by":"publisher","award":["No number"],"award-info":[{"award-number":["No number"]}],"id":[{"id":"10.13039\/100005384","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02676-8","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:16:40Z","timestamp":1768551400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interruption of cross-communication pathways alters the immune cell signature of pancreatic cancer and decreases tumor growth"],"prefix":"10.1186","volume":"24","author":[{"given":"Jill P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdis","family":"Mohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joi","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Drda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha D.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Gomeiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Shivapurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellah","family":"Akhrif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaelena","family":"Pierobon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2676_CR1","doi-asserted-by":"publisher","unstructured":"Truong LH, Pauklin S. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches. Cancers (Basel). 2021;13(19):5028. https:\/\/doi.org\/10.3390\/cancers13195028.","DOI":"10.3390\/cancers13195028"},{"key":"2676_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41419-021-04258-7","volume":"12","author":"CH Chang","year":"2021","unstructured":"Chang CH, Pauklin S. Extracellular vesicles in pancreatic cancer progression and therapies. Cell Death Dis. 2021;12:973.","journal-title":"Cell Death Dis"},{"key":"2676_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21037\/tgh-23-53","volume":"9","author":"A Panda","year":"2024","unstructured":"Panda A, Falasca M, Ragunath K. Extracellular vesicles in pancreatic cancer: a new era in precision medicine. Transl Gastroenterol Hepatol. 2024;9:29.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"2676_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1158\/1541-7786.MCR-20-0439","volume":"18","author":"KC Honselmann","year":"2020","unstructured":"Honselmann KC, Finetti P, Birnbaum DJ, Monsalve CS, Wellner UF, Begg SKS, et al. Neoplastic-stromal cell cross-talk regulates matrisome expression in pancreatic cancer. Mol Cancer Res. 2020;18:1889\u2013902.","journal-title":"Mol Cancer Res"},{"key":"2676_CR5","doi-asserted-by":"publisher","first-page":"101608","DOI":"10.1016\/j.jbc.2022.101608","volume":"298","author":"B Geleta","year":"2022","unstructured":"Geleta B, Tout FS, Lim SC, Sahni S, Jansson PJ, Apte MV, et al. Targeting Wnt\/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. J Biol Chem. 2022;298:101608.","journal-title":"J Biol Chem"},{"key":"2676_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1158\/2326-6066.CIR-17-0198","volume":"6","author":"R Samaniego","year":"2018","unstructured":"Samaniego R, Gutierrez-Gonzalez A, Gutierrez-Seijo A, Sanchez-Gregorio S, Garcia-Gimenez J, Mercader E, et al. Ccl20 expression by tumor-associated macrophages predicts progression of human primary cutaneous melanoma. Cancer Immunol Res. 2018;6(3):267\u201375.","journal-title":"Cancer Immunol Res"},{"key":"2676_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1479-5876-8-45","volume":"8","author":"C Rubie","year":"2010","unstructured":"Rubie C, Frick VO, Ghadjar P, Wagner M, Grimm H, Vicinus B, et al. CCL20\/CCR6 expression profile in pancreatic cancer. J Transl Med. 2010;8:45.","journal-title":"J Transl Med"},{"key":"2676_CR8","doi-asserted-by":"crossref","unstructured":"Kadomoto, S.; Izumi, K.; Mizokami, A. Roles of CCL2-CCR2 Axis in the Tumor Microenvironment. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22168530"},{"key":"2676_CR9","doi-asserted-by":"publisher","first-page":"108598","DOI":"10.1016\/j.intimp.2022.108598","volume":"106","author":"X Li","year":"2022","unstructured":"Li X, He G, Liu J, Yan M, Shen M, Xu L, et al. CCL2-mediated monocytes regulate immune checkpoint blockade resistance in pancreatic cancer. Int Immunopharmacol. 2022;106:108598.","journal-title":"Int Immunopharmacol"},{"key":"2676_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799\u2013820.","journal-title":"Nat Rev Drug Discov"},{"key":"2676_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8:31.","journal-title":"NPJ Precis Oncol"},{"key":"2676_CR12","doi-asserted-by":"crossref","unstructured":"Malchiodi ZX, Cao H, Gay MD, Safronenka A, Bansal S, Tucker RD, Weinberg BA, Cheema A, Shivapurkar N, Smith JP. Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment. Cancers (Basel). 2021;13(19):4949.","DOI":"10.3390\/cancers13194949"},{"key":"2676_CR13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s10620-019-05863-5","volume":"65","author":"S Nadella","year":"2020","unstructured":"Nadella S, Ciofoaia V, Cao H, Kallakury B, Tucker RD, Smith JP. Cholecystokinin receptor antagonist therapy decreases inflammation and fibrosis in chronic pancreatitis. Dig Dis Sci. 2020;65:1376\u201384.","journal-title":"Dig Dis Sci"},{"key":"2676_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10620-019-05722-3","volume":"65","author":"RD Tucker","year":"2020","unstructured":"Tucker RD, Ciofoaia V, Nadella S, Gay MD, Cao H, Huber M, et al. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. Dig Dis Sci. 2020;65:189\u2013203.","journal-title":"Dig Dis Sci"},{"key":"2676_CR15","doi-asserted-by":"crossref","unstructured":"Gay MD, Cao H, Shivapurkar N, Dakshanamurthy S, Kallakury B, Tucker RD, Kwagyan J, Smith JP. Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome. Int J Mol Sci. 2022;23(3):1899.","DOI":"10.3390\/ijms23031899"},{"key":"2676_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/abbs\/gmw101","volume":"48","author":"B Liu","year":"2016","unstructured":"Liu B, Jia Y, Ma J, Wu S, Jiang H, Cao Y, et al. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer. Acta Biochim Biophys Sin. 2016;48:1067\u201374.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2676_CR17","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","volume":"19","author":"DE Sanford","year":"2013","unstructured":"Sanford DE, Belt BA, Panni RZ, Mayer A, Deshpande AD, Carpenter D, et al. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis. Clin Cancer Res. 2013;19:3404\u201315.","journal-title":"Clin Cancer Res"},{"key":"2676_CR18","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","volume":"192","author":"E Sierra-Filardi","year":"2014","unstructured":"Sierra-Filardi E, Nieto C, Dominguez-Soto A, Barroso R, Sanchez-Mateos P, Puig-Kroger A, et al. Ccl2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2\/CCR2-dependent gene expression profile. J Immunol. 2014;192:3858\u201367.","journal-title":"J Immunol"},{"key":"2676_CR19","doi-asserted-by":"crossref","unstructured":"Steinberg E, Orehov N, Tischenko K, Schwob O, Zamir G, Hubert A, Manevitch Z, Benny O. Rapid Clearing for High Resolution 3D Imaging of Ex Vivo Pancreatic Cancer Spheroids. Int J Mol Sci. 2020;21(20):7703.","DOI":"10.3390\/ijms21207703"},{"key":"2676_CR20","doi-asserted-by":"crossref","unstructured":"Foty R. A simple hanging drop cell culture protocol for generation of 3D spheroids. J Vis Exp. 2011(51):2720.","DOI":"10.3791\/2720-v"},{"key":"2676_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12964-024-01742-3","volume":"22","author":"CE Blanchard","year":"2024","unstructured":"Blanchard CE, Gomeiz AT, Avery K, Gazzah EE, Alsubaie AM, Sikaroodi M, et al. Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds. Cell Commun Signal. 2024;22:377.","journal-title":"Cell Commun Signal"},{"key":"2676_CR22","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1158\/1078-0432.CCR-16-2656","volume":"23","author":"M Pierobon","year":"2017","unstructured":"Pierobon M, Ramos C, Wong S, Hodge KA, Aldrich J, Byron S, et al. Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer. Clin Cancer Res. 2017;23:4919\u201328.","journal-title":"Clin Cancer Res"},{"key":"2676_CR23","doi-asserted-by":"crossref","unstructured":"Baldelli, E.; Calvert, V.; Hodge, A.; VanMeter, A.; Petricoin, E.F., III; Pierobon, M. Reverse Phase Protein Microarrays. Methods Mol Biol. 2017;1606:149\u2013169.","DOI":"10.1007\/978-1-4939-6990-6_11"},{"key":"2676_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-4939-6990-6_4","volume":"1606","author":"M Signore","year":"2017","unstructured":"Signore M, Manganelli V, Hodge A. Antibody validation by western blotting. Methods Mol Biol. 2017;1606:51\u201370.","journal-title":"Methods Mol Biol"},{"key":"2676_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/0471140864.ps2707s75","volume":"75","author":"E Pin","year":"2014","unstructured":"Pin E, Federici G, Petricoin EF III. Preparation and use of reverse protein microarrays. Curr Protoc Protein Sci. 2014;75:27.","journal-title":"Curr Protoc Protein Sci"},{"key":"2676_CR26","doi-asserted-by":"publisher","first-page":"112721","DOI":"10.1016\/j.jim.2019.112721","volume":"478","author":"EW Baxter","year":"2020","unstructured":"Baxter EW, Graham AE, Re NA, Carr IM, Robinson JI, Mackie SL, et al. Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNgamma+LPS), M(IL-4) and M(IL-10) phenotypes. J Immunol Methods. 2020;478:112721.","journal-title":"J Immunol Methods"},{"key":"2676_CR27","first-page":"101383","volume":"32","author":"CR Nascimento","year":"2022","unstructured":"Nascimento CR, Rodrigues Fernandes NA, Gonzalez Maldonado LA, Rossa JC. Comparison of monocytic cell lines U937 and THP-1 as macrophage models for in vitro studies. Biochem Biophys Rep. 2022;32:101383.","journal-title":"Biochem Biophys Rep"},{"key":"2676_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cas.13155","volume":"108","author":"T Ishiguro","year":"2017","unstructured":"Ishiguro T, Ohata H, Sato A, Yamawaki K, Enomoto T, Okamoto K. Tumor-derived spheroids: relevance to cancer stem cells and clinical applications. Cancer Sci. 2017;108:283\u20139.","journal-title":"Cancer Sci"},{"key":"2676_CR29","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1053\/j.gastro.2022.02.017","volume":"162","author":"X Shi","year":"2022","unstructured":"Shi X, Yang J, Liu M, Zhang Y, Zhou Z, Luo W, et al. Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-beta Signaling Axis in Pancreatic Cancer. Gastroenterology. 2022;162:2004\u201317.","journal-title":"Gastroenterology"},{"key":"2676_CR30","doi-asserted-by":"crossref","unstructured":"Borden KLB. The Nuclear Pore Complex and mRNA Export in Cancer. Cancers (Basel). 2020;13(1):42.","DOI":"10.3390\/cancers13010042"},{"key":"2676_CR31","doi-asserted-by":"publisher","first-page":"200963","DOI":"10.1016\/j.omton.2025.200963","volume":"33","author":"X Tang","year":"2025","unstructured":"Tang X, Jiang N, Kou Y, Cheng S, Yan F. PLA2G4F is a metabolic checkpoint in triple-negative breast cancer: insights from multiple omics analysis and experiments. Mol Ther Oncolytics. 2025;33:200963.","journal-title":"Mol Ther Oncolytics"},{"key":"2676_CR32","doi-asserted-by":"publisher","first-page":"708900","DOI":"10.3389\/fonc.2021.708900","volume":"11","author":"Y Yang","year":"2021","unstructured":"Yang Y, Gao L, Weng NN, Li JJ, Liu JL, Zhou Y, et al. Identification of novel molecular therapeutic targets and their potential prognostic biomarkers among kinesin superfamily of proteins in pancreatic ductal adenocarcinoma. Front Oncol. 2021;11:708900.","journal-title":"Front Oncol"},{"key":"2676_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.18632\/genesandcancer.179","volume":"9","author":"KMK Al-Taee","year":"2018","unstructured":"Al-Taee KMK, Zepp M, Berger I, Berger MR, Adwan H. Pancreatic carcinoma cells colonizing the liver modulate the expression of their extracellular matrix genes. Genes Cancer. 2018;9:215\u201331.","journal-title":"Genes Cancer"},{"key":"2676_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/ol.2021.12484","volume":"21","author":"X Yang","year":"2021","unstructured":"Yang X, Wu Q, Wu F, Zhong Y. Differential expression of COL4A3 and collagen in upward and downward progressing types of nasopharyngeal carcinoma. Oncol Lett. 2021;21:223.","journal-title":"Oncol Lett"},{"key":"2676_CR35","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/2767-9764.CRC-24-0281","volume":"4","author":"MF McDonald","year":"2024","unstructured":"McDonald MF, Curry RN, O\u2019Reilly I, Lozzi B, Cervantes A, Lee ZF, et al. Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression. Cancer Res Commun. 2024;4:3209\u201323.","journal-title":"Cancer Res Commun"},{"key":"2676_CR36","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.18632\/aging.204877","volume":"15","author":"H Chen","year":"2023","unstructured":"Chen H, Liang W, Zheng W, Li F, Pan X, Lu Y. A novel telomere-related gene prognostic signature for survival and drug treatment efficiency prediction in lung adenocarcinoma. Aging (Albany NY). 2023;15:7956\u201373.","journal-title":"Aging (Albany NY)"},{"key":"2676_CR37","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/1541-7786.MCR-13-0557-T","volume":"12","author":"C Mehner","year":"2014","unstructured":"Mehner C, Miller E, Khauv D, Nassar A, Oberg AL, Bamlet WR, et al. Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma. Mol Cancer Res. 2014;12:1430\u20139.","journal-title":"Mol Cancer Res"},{"key":"2676_CR38","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.bbamcr.2015.05.011","volume":"1853","author":"B Nuche-Berenguer","year":"2015","unstructured":"Nuche-Berenguer B, Jensen RT. Gastrointestinal hormones\/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms. Biochim Biophys Acta. 2015;1853:2371\u201382.","journal-title":"Biochim Biophys Acta"},{"key":"2676_CR39","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/MPA.0000000000001360","volume":"48","author":"S Nadella","year":"2019","unstructured":"Nadella S, Burks J, Huber M, Wang J, Cao H, Kallakury B, et al. Endogenous gastrin collaborates with mutant KRAS in pancreatic carcinogenesis. Pancreas. 2019;48:894\u2013903.","journal-title":"Pancreas"},{"key":"2676_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC. NF-kappaB in inflammation and cancer. Cell Mol Immunol. 2025;22:811\u201339.","journal-title":"Cell Mol Immunol"},{"key":"2676_CR41","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1111\/jcmm.16213","volume":"25","author":"N Wu","year":"2021","unstructured":"Wu N, Xu XF, Xin JQ, Fan JW, Wei YY, Peng QX, et al. The effects of nuclear factor-kappa B in pancreatic stellate cells on inflammation and fibrosis of chronic pancreatitis. J Cell Mol Med. 2021;25:2213\u201327.","journal-title":"J Cell Mol Med"},{"key":"2676_CR42","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/00130404-200411000-00007","volume":"10","author":"TF Kimsey","year":"2004","unstructured":"Kimsey TF, Campbell AS, Albo D, Wilson M, Wang TN. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J. 2004;10:374\u201380.","journal-title":"Cancer J"},{"key":"2676_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj20030312","volume":"374","author":"TD Werry","year":"2003","unstructured":"Werry TD, Wilkinson GF, Willars GB. Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochem J. 2003;374:281\u201396.","journal-title":"Biochem J"},{"key":"2676_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fphys.2018.00335","volume":"9","author":"D Murthy","year":"2018","unstructured":"Murthy D, Attri KS, Singh PK. Phosphoinositide 3-kinase signaling pathway in pancreatic ductal adenocarcinoma progression, pathogenesis, and therapeutics. Front Physiol. 2018;9:335.","journal-title":"Front Physiol"},{"key":"2676_CR45","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1136\/gutjnl-2024-332225","volume":"73","author":"Y Lin","year":"2024","unstructured":"Lin Y, Pu S, Wang J, Wan Y, Wu Z, Guo Y, et al. Pancreatic STAT5 activation promotes Kras(G12D)-induced and inflammation-induced acinar-to-ductal metaplasia and pancreatic cancer. Gut. 2024;73:1831\u201343.","journal-title":"Gut"},{"key":"2676_CR46","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.3389\/fimmu.2019.01804","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, Xia X, Mao L, Wang S. The CCAAT\/enhancer-binding protein family: its roles in MDSC expansion and function. Front Immunol. 2019;10:1804.","journal-title":"Front Immunol"},{"key":"2676_CR47","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2147\/OTT.S238706","volume":"13","author":"HY Piao","year":"2020","unstructured":"Piao HY, Guo S, Wang Y, Zhang J. Exosomal long non-coding RNA CEBPA-AS1 inhibits tumor apoptosis and functions as a non-invasive biomarker for diagnosis of gastric cancer. Onco Targets Ther. 2020;13:1365\u201374.","journal-title":"Onco Targets Ther"},{"key":"2676_CR48","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1161\/01.CIR.0000072792.65250.4A","volume":"107","author":"CM Dollery","year":"2003","unstructured":"Dollery CM, Owen CA, Sukhova GK, Krettek A, Shapiro SD, Libby P. Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation. 2003;107:2829\u201336.","journal-title":"Circulation"},{"key":"2676_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.steroids.2017.11.006","volume":"133","author":"I Lerman","year":"2018","unstructured":"Lerman I, Hammes SR. Neutrophil elastase in the tumor microenvironment. Steroids. 2018;133:96\u2013101.","journal-title":"Steroids"},{"key":"2676_CR50","doi-asserted-by":"crossref","unstructured":"Demkow U. Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis. Cancers (Basel). 2021;13(17):4495.","DOI":"10.3390\/cancers13174495"},{"key":"2676_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01010-3","volume":"15","author":"W Jia","year":"2024","unstructured":"Jia W, Mao Y, Luo Q, Wu J, Guan Q. Targeting neutrophil elastase is a promising direction for future cancer treatment. Discover Oncol. 2024;15:167.","journal-title":"Discover Oncol"},{"key":"2676_CR52","doi-asserted-by":"crossref","unstructured":"Pratt HG, Steinberger KJ, Mihalik NE, Ott S, Whalley T, Szomolay B, Boone BA, Eubank TD. Macrophage and Neutrophil Interactions in the Pancreatic Tumor Microenvironment Drive the Pathogenesis of Pancreatic Cancer. Cancers (Basel). 2021;14(1):194.","DOI":"10.3390\/cancers14010194"},{"key":"2676_CR53","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4251\/wjgo.v13.i8.915","volume":"13","author":"K Shin","year":"2021","unstructured":"Shin K, Jung EK, Park SJ, Jeong S, Kim IH, Lee MA. Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19\u20139 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy. World J Gastrointest Oncol. 2021;13:915\u201328.","journal-title":"World J Gastrointest Oncol"},{"key":"2676_CR54","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","volume":"133","author":"MA Giese","year":"2019","unstructured":"Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019;133:2159\u201367.","journal-title":"Blood"},{"key":"2676_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening TM, Wang-Gillam A, Sanford DE, Belt BA, Panni RZ, Cusworth BM, et al. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 2016;17:651\u201362.","journal-title":"Lancet Oncol"},{"key":"2676_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","volume":"43","author":"CT Kureshi","year":"2025","unstructured":"Kureshi CT, Dougan SK. Cytokines in cancer. Cancer Cell. 2025;43:15\u201335.","journal-title":"Cancer Cell"},{"key":"2676_CR57","doi-asserted-by":"publisher","first-page":"101696","DOI":"10.1016\/j.xcrm.2024.101696","volume":"5","author":"MS Alam","year":"2024","unstructured":"Alam MS, Gaida MM, Witzel HR, Otsuka S, Abbasi A, Guerin T, et al. Tnfr1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function. Cell Rep Med. 2024;5:101696.","journal-title":"Cell Rep Med"},{"key":"2676_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jss.2019.02.038","volume":"240","author":"D Imai","year":"2019","unstructured":"Imai D, Yoshizumi T, Okano S, Itoh S, Ikegami T, Harada N, et al. IFN-gamma promotes epithelial-mesenchymal transition and the expression of PD-L1 in pancreatic cancer. J Surg Res. 2019;240:115\u201323.","journal-title":"J Surg Res"},{"key":"2676_CR59","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/cpt.2745","volume":"112","author":"A Rabiee","year":"2022","unstructured":"Rabiee A, Gay MD, Shivapurkar N, Cao H, Nadella S, Smith CI, et al. Safety and dosing study of a cholecystokinin receptor antagonist in non-alcoholic steatohepatitis. Clin Pharmacol Ther. 2022;112:1271\u20139.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02676-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02676-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02676-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:58:11Z","timestamp":1769835491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02676-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2676"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02676-8","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Competing Interests: Georgetown University owns an issued patent for the use of proglumide in pancreatic cancer and Dr Jill Smith is a co-inventor; Mariaelena Pierobon is an inventor of university-assigned patents and patent applications and received royalties from and consulted for TheraLink Technologies. The other authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}